eCommons

 

Part I: Total Synthesis Of Aspeverin And Penicimutamide A. Part Ii: Total Chemical Synthesis Of All-L And All-D Kras(G12V) And The Further Exploration Of Isonitrile Mediated Peptide Ligations

Other Titles

Abstract

Part I: Fungi serve as a rich source of prenylated indole alkaloids, which exhibit important biological activities including antiproliferative, antibiotic, and antihelminthic properties. Their promise as therapeutics, coupled with their diverse and complex molecular architectures, have made prenylated indole alkaloids popular targets for synthetic chemists in order to probe their activities and develop new synthetic methods. Herein, we describe the first total synthesis of aspeverin, a unique bridged carbamate-containing prenylated indole alkaloid isolated from Aspergillus versicolor. We also describe the synthesis of a closely related congener, penicimutamide A, isolated from a mutant strain of Penicillium purpurogenum. These molecules belong to a recently described subclass of prenylated indoles thought to be degradation products of parent bicyclo[2.2.2]diazaoctane congeners. In this research, we showcase a highly diastereoselective Diels?Alder cycloaddition, followed by an electrophilic Rawal arylation – reductive indolization to forge the pentacyclic scaffold of these natural products. A novel sequence for installation of a geminal dimethyl group was also developed. This involved a carefully devised transannular carbamate cyclization followed by a ring-opening / alkylation sequence. Finally, the bridging carbamate common to both of these natural products was forged using a hypervalent iodine(III)-mediated oxidative cyclization. Part II: The KRas protein is a small GTP-binding protein important in cellular signaling, involved in growth, differentiation, motility, and survival. Oncogenic mutated Ras is involved in approximately 30% of all cancers. Despite the identification of this target in human cancers over 30 years ago, no small molecules targeting KRas have been successful in the clinic, and this target has long been considered “undruggable.” In an effort to develop novel therapeutics, this project seeks to complete a total synthesis of an all-D amino acid variant of the KRas protein. This synthetic protein enantiomer will be used as a tool for mirror-image yeast surface display studies to identify all-D residue peptide ligands for KRas. In this section, the synthesis of biotinylated variants of KRas(G12V) consisting of all-L and all-D amino acid residues is described. Moreover, we demonstrate that this enantiomeric pair of 166-residue proteins bind to nucleotide substrates as well as Ras-binding peptides with enantiospecificity. During our studies on the total synthesis of KRas, we further demonstrate the utility of isonitrile-mediated activation of C-terminal thiocarboxylic acids for peptide ligation. This method is advantageous, in that it does not rely on a cysteine disconnection and takes place under mild conditions in polar aprotic organic solvents. Beyond a synthesis of KRas, we also demonstrate that isonitrile-mediated ligation and native chemical ligation strategies can be combined and applied toward a novel synthesis of HIV-1 protease I66A.

Journal / Series

Volume & Issue

Description

Sponsorship

Date Issued

2017

Publisher

Keywords

Aspeverin; Peptide Synthesis; Prenylated Indole Alkaloid; Ras; Total Synthesis

Location

Effective Date

Expiration Date

Sector

Employer

Union

Union Local

NAICS

Number of Workers

Committee Chair

Committee Co-Chair

Committee Member

Degree Discipline

Chemical Biology

Degree Name

Degree Level

Doctor of Philosophy

Related Version

Related DOI

Related To

Related Part

Based on Related Item

Has Other Format(s)

Part of Related Item

Related To

Related Publication(s)

Link(s) to Related Publication(s)

References

Link(s) to Reference(s)

Previously Published As

Government Document

ISBN

ISMN

ISSN

Other Identifiers

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

Types

dissertation or thesis

Accessibility Feature

Accessibility Hazard

Accessibility Summary

Link(s) to Catalog Record